Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one

Peptide(540–548), peptide(611–626), peptide(672–686) and peptide(766–780), which are derived from human telomerase, constitute the immunogenic component of the GX301 cancer vaccine. The relative immunogenicity of these peptides is unknown, thus it is unsure whether their combined use offers real adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenoglio, Daniela, Parodi, Alessia, Lavieri, Rosa, Kalli, Francesca, Ferrera, Francesca, Tagliamacco, Augusto, Guastalla, Andrea, Lamperti, Maria Giuseppina, Giacomini, Mauro, Filaci, Gilberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514186/
https://www.ncbi.nlm.nih.gov/pubmed/25714118
http://dx.doi.org/10.1080/21645515.2015.1012032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514186/
https://www.ncbi.nlm.nih.gov/pubmed/25714118
http://dx.doi.org/10.1080/21645515.2015.1012032

Ejemplares similares